Newsletter 4

Lattice Biologics Newsletter Issue 4: August 31, 2015

HIGHLIGHT: Learn about one of the most vital technologies our team has been developing and testing over the past year.  This newsletter includes an overview of ECM technology and articles.

As a developer and manufacturer of high quality allografts (biologic products derived from donor tissue) for use in a variety of surgical applications, including: breast reconstruction; spine, knee, and joint surgeries; burn care; wound care; and sports medicine, we are passionate about honoring the gift of tissue donation and have devoted extensive research into how to improve the surgical outcomes for patients.  This was the impetus for developing Next Generation Allograft Technology that drastically improves post-surgical healing and reduces recovery time for allograft recipients.  These improvements translate into meaningful benefits and life-changing wellness.

NEW SAB MEMBER: We are thrilled to announce the addition of Dr. Marc J. Jeschke, MD, PhD, FACS, FCCM, FRCS(C), an internationally recognized and published leader in burns, trauma, and wound care, to our SAB.  Dr. Jeschke has been caring for burn patients and conducting valuable research in the field for nearly 20 years.  Get to know Dr. Jeschke.

(About the Lattice Biologics Newsletter: Covering news and advancements in personalized medicine, precision medicine, and regenerative medicine and our progress in cellular therapies and tissue engineering. Taking Arizona Biomedical products to international markets.)

Read the complete newsletter here.

Click Subscribe to receive updates.


Media Contact: Melanie Battista, Public Relations, Lattice Biologics Inc., 16701 N 90th Street, Suite #101, Scottsdale, AZ 85260, 480-563-0800 Office, |

Subscribe to Lattice News Updates

Follow us on Twitter: @LatticeBio